ABOUT THE EXPERT

Dermatology / Plaque Psoriasis

patient care perspectives by Steven R. Feldman, MD, PhD

In patients with psoriasis, a disease flare may result from a loss of response (eg, due to antidrug antibodies), increased disease activity, or adh...READ MORE

Dermatology / Plaque Psoriasis

expert roundtables by Steven R. Feldman, MD, PhD; Joel M. Gelfand, MD, MSCE; and Alice B. Gottlieb, MD, PhD

Although data are limited, outcomes for patients with psoriasis who become infected with SARS-CoV-2 seem to be driven by age and the previously ide...READ MORE

Dermatology / Plaque Psoriasis

clinical topic updates by Steven R. Feldman, MD, PhD

Psoriasis induced by tumor necrosis factor–α  inhibitor (TNFi) therapy is a relatively uncommon side effect that may occur during the treatment of ...READ MORE

Dermatology / Plaque Psoriasis

expert roundtables by Steven R. Feldman, MD, PhD; Joel M. Gelfand, MD, MSCE; and Alice B. Gottlieb, MD, PhD

Today, classes of biologics for moderate to severe plaque psoriasis include the tumor necrosis factor (TNF) inhibitors, interleukin-17 (IL-17) inhi...READ MORE